The week in review


Pharmacy has been under fire from several directions this week, as the dust settles following the release of the King review interim paper

Pharmacy was condemned in mainstream media this week for its wariness of participating in the King Review‘s financial survey, which the Guild says suffered from a “straight-out conflict of interest”. And News Corp published a piece that was highly critical of the sector over script price variation.

We took a look at how the Review Interim Paper suggests pharmacy professional services are grievously underfunded and at SHPA‘s thoughts on how to harness the expertise of hospital pharmacists.

Stakeholders got together to label the interim paper a “step backwards“. And we want to know what you think of it… tell us here.

GPs have been making news, whether because they’ve been slammed for overprescribing antibiotics, or because they’ve been criticising Sigma‘s new screening initiative, which rolled out through its Amcal Pharmacy network this week. However the Royal College of Pathologists of Australasia gave the program the thumbs up. Pharmacy also came under fire for selling homeopathy.

A new financial year starts today, and so pharmacists, pharmacy assistants and students should see an increase in their pay packet of 3.3%. And controversy continues over penalty rates as the 1 July milestone passes, meaning the first round of penalty rates cuts will now take place for affected employees, to the disgust of Opposition leader Bill Shorten.

Previous Skincare: time to reap the rewards
Next Balancing the books

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.